Janus Living, Inc. (JAN)
| Market Cap | 8.39B |
| Revenue (ttm) | 655.41M +6.2% |
| Net Income | -97,000 |
| EPS | -0.02 |
| Shares Out | 288.14M |
| PE Ratio | n/a |
| Forward PE | 176.87 |
| Dividend | $0.57 (1.94%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 813,257 |
| Open | 29.46 |
| Previous Close | 29.32 |
| Day's Range | 29.10 - 29.51 |
| 52-Week Range | 22.76 - 30.08 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 30.45 (+4.53%) |
| Earnings Date | Aug 4, 2026 |
About JAN
Janus Living, Inc. is the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT. The firm’s entire portfolio is owned and operated under RIDEA structures. The Firm’s initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. It’s communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025. All of the communities are ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for JAN stock is "Buy." The 12-month stock price target is $30.45, which is an increase of 4.53% from the latest price.
News
Janus Living Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2026
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced that on July 8, 2026, its Board of Directors declare...
Janus Living price target raised to $33 from $30 at Barclays
Barclays raised the firm’s price target on Janus Living (JAN) to $33 from $30 and keeps an Overweight rating on the shares.
Janus Living price target lowered to $29 from $30 at Scotiabank
Scotiabank lowered the firm’s price target on Janus Living (JAN) to $29 from $30 and keeps an Outperform rating on the shares. The firm sees real estate investment trust valuations…
Janus Living initiated with a Strong Buy at Raymond James
Raymond James initiated coverage of Janus Living (JAN) with a Strong Buy rating and $34 price target. The recent Janus Living IPO resulted in a pure-play Senior Housing REIT with…
Janus Living Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN), a pure-play senior housing real estate investment trust (REIT), is scheduled to report second quarter 2026 financial results after the close of...
Janus Living price target raised to $29 from $28 at KeyBanc
KeyBanc raised the firm’s price target on Janus Living (JAN) to $29 from $28 and keeps an Overweight rating on the shares. Following last week’s nearly $600M equity issuance, Janus’…
Janus Living 25M share Secondary priced at $25.00
The deal priced below last closing price of $25.45. BofA, JPMorgan, RBC Capital and Wells Fargo are acting as joint book running managers for the offering.
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today the pricing of its public offering of 25,000,0...
Janus Living launches public offering of 25M shares of Class A-1 stock
Janus Living (JAN) announced the launch of its public offering of 25,000,000 shares of its Class A-1 common stock pursuant to a registration statement on Form S-11 filed with the…
Janus Living Announces Launch of Public Offering of Class A-1 Common Stock
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today the launch of its public offering of 25,000,00...
Janus Living Registration statement: Registration filing
Janus Living filed a registration statement on June 1, 2026, providing details about a securities offering with the SEC.
Janus Living price target raised to $30 from $28 at Scotiabank
Scotiabank raised the firm’s price target on Janus Living (JAN) to $30 from $28 and keeps an Outperform rating on the shares. The firm is updating its estimates for U.S.
Janus Living price target raised to $30 from $26 at Barclays
Barclays analyst Richard Hightower raised the firm’s price target on Janus Living (JAN) to $30 from $26 and keeps an Overweight rating on the shares post the Q1 report. The…
Janus Living price target raised to $30 from $27 at RBC Capital
RBC Capital analyst Michael Carroll raised the firm’s price target on Janus Living (JAN) to $30 from $27 and keeps an Outperform rating on the shares. The company delivered a…
Janus Living Declares Common Stock Cash Dividends for the First and Second Quarters of 2026
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN), a pure-play senior housing real estate investment trust (REIT), announced its Board of Directors today declared a pro rata quarterly common sto...
Janus Living Earnings Call Transcript: Q1 2026
Strong 1Q 2026 results with 35% revenue growth, robust occupancy gains, and record entrance fee sales. IPO proceeds and new credit facilities provide ample liquidity for $750M in targeted acquisitions, with guidance raised for NOI growth and FFO per share.
Janus Living Earnings release: Q1 2026
Janus Living released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Janus Living Quarterly report: Q1 2026
Janus Living has published its Q1 2026 quarterly earnings report on May 6, 2026.
Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the quarter...
Janus Living Reports First Quarter 2026 Results
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN), a pure-play senior housing real estate investment trust (REIT), announced results for the quarter ended March 31, 2026. FIRST QUARTER 2026 FINA...
Janus Living initiated with an Outperform at Scotiabank
Scotiabank initiated coverage of Janus Living (JAN) with an Outperform rating and $28 price target The firm says Janus offers one of the highest funds from operations growth outlooks in…
Janus Living initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Julien Blouin initiated coverage of Janus Living (JAN) with a Neutral rating and $27 price target The rating reflects a balance between strong long-term tailwinds in senior…
Janus Living initiated with a Buy at BofA
BofA initiated coverage of Janus Living (JAN) with a Buy rating and $29 price target. The pure-play senior housing REIT externally managed by Healthpeak Properties (DOC) has 100% NOI exposure…
Janus Living initiated with an Outperform at BNP Paribas
BNP Paribas initiated coverage of Janus Living (JAN) with an Outperform rating and $27 price target
Janus Living initiated with a Buy at BofA
BofA analyst Farrell Granath initiated coverage of Janus Living (JAN) with a Buy rating and $29 price target